{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:18:53Z","timestamp":1790734733272,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["NCT04049045"],"award-info":[{"award-number":["NCT04049045"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sodium-glucose co-transporter 2 (SGLT2) inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies. Transthoracic echocardiography (TTE) is frequently used to assess heart function and dimensions in acute heart failure to lead therapy and assess volume status. Immediate changes, especially of left heart haemodynamic parameters, measured by echocardiography in patients with acute heart failure treated with SGLT2 inhibitors, remain unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of this pre-defined secondary analysis was to assess whether treatment with empagliflozin 25\u00a0mg\/day in patients with acute heart failure improves echocardiographic parameters of load, left ventricular or right ventricular function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>In the single-centre, prospective, double-blind, placebo-controlled EMPAG-HF trial, patients with acute decompensated heart failure (ADHF) were screened and randomized within 12 h following hospital admission to receive either empagliflozin or placebo in addition to standard medical treatment over 5 days. Sixty patients were enrolled and randomized irrespective of left ventricular ejection fraction or diabetes. All patients received 2D TTE on admission (tB\u00a0=\u00a0at baseline) and after completing the study treatment (tC\u00a0=\u00a0time after completing study medication) (according to study design). The recorded loops were analysed using dedicated software (Image-Arena\u2122 Version 4.6; TomTec Imaging Systems). After 5 days of treatment, patients in the empagliflozin cohort showed a relevant decrease in left atrial volume [LAV: \u2206tB-tC\u00a0=\u00a030.9\u00a0\u00b1\u00a027.4; 95% confidence interval (CI) 20.1\u201341.7) compared to placebo \u2206tB-tC\u00a0=\u00a010.5\u00a0\u00b1\u00a026; 95% CI 0.4\u201320.5; P = &amp;lt;0.001] and left atrial end-systolic volume index (LAESVI: \u2206tB-tC\u00a0=\u00a015.7\u00a0\u00b1\u00a015.1; 95% CI 9.8\u201321.6\u00a0vs. placebo \u2206tB-tC\u00a0=\u00a09.7\u00a0\u00b1\u00a010.2; 95% CI 5.7\u201313.6; P\u00a0=\u00a00.016) compared to placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Immediate addition of empagliflozin to standard therapy improves echocardiographic parameters of LAV in patients following recompensation of ADHF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvaf003","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:07:12Z","timestamp":1741129632000},"page":"190-197","source":"Crossref","is-referenced-by-count":12,"title":["Acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography\u2014a subanalysis of the EMPAG-HF trial"],"prefix":"10.1093","volume":"11","author":[{"given":"Jurgen","family":"Bogoviku","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Dung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Georg","family":"Westphal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Aftanski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Moebius-Winkler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4883-5176","authenticated-orcid":false,"given":"Franz","family":"Haertel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sissy","family":"Grund","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hamadanchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-6156","authenticated-orcid":false,"given":"Martin","family":"Busch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Division of Nephrology, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Christian","family":"Schulze","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University , Am Klinikum 1 Haus A, 07747 Jena ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"2025031314291316600_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"Mcdonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2025031314291316600_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"Jones","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib4","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1002\/ehf2.13760","article-title":"A year in heart failure: an update of recent findings","volume":"8","author":"Stretti","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025031314291316600_bib5","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"2025031314291316600_bib6","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/eurheartj\/ehv066","article-title":"Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine\u2014short version","volume":"36","author":"Mebazaa","year":"2015","journal-title":"Eur Heart J"},{"key":"2025031314291316600_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2018.05.038","article-title":"Mechanical unloading in heart failure","volume":"72","author":"Uriel","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025031314291316600_bib8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib9","first-page":"17","article-title":"Loop diuretics in clinical practice","volume-title":"Electrolyte Blood Press","author":"Oh","year":"2015"},{"key":"2025031314291316600_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2025031314291316600_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2025031314291316600_bib12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2025031314291316600_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"Mcmurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2025031314291316600_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2025031314291316600_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: emperor-preserved trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"2025031314291316600_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrcardio.2017.56","article-title":"Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure","volume":"14","author":"Price","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2025031314291316600_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"2025031314291316600_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2025031314291316600_bib20","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ejhf.2967","article-title":"Sodium-glucose cotransporter-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies","volume":"25","author":"Biegus","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib22","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1093\/eurheartj\/ehac427","article-title":"Empagliflozin in patients hospitalized for acute heart failure","volume":"43","author":"Ponikowski","year":"2022","journal-title":"Eur Heart J"},{"key":"2025031314291316600_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12933-024-02504-8","article-title":"Sglt2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (tavi)","volume":"23","author":"Paolisso","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2025031314291316600_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2005.07.126","article-title":"Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons &gt;or =65 years of age (the cardiovascular health study)","volume":"97","author":"Gottdiener","year":"2006","journal-title":"Am J Cardiol"},{"key":"2025031314291316600_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.acvd.2011.10.004","article-title":"Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis","volume":"104","author":"Mohty","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"2025031314291316600_bib26","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/01.CIR.0000066318.21784.43","article-title":"Left atrial volume: a powerful predictor of survival after acute myocardial infarction","volume":"107","author":"M\u00f8ller","year":"2003","journal-title":"Circulation"},{"key":"2025031314291316600_bib27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjcard.2004.05.060","article-title":"Usefulness of left atrial volume as a predictor of mortality in patients with ischemic cardiomyopathy","volume":"94","author":"Sabharwal","year":"2004","journal-title":"Am J Cardiol"},{"key":"2025031314291316600_bib28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"2025031314291316600_bib29","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2022.08.807","article-title":"Randomized trials of percutaneous microaxial flow pump devices: JACC state-of-the-art review","volume":"80","author":"Pahuja","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025031314291316600_bib30","first-page":"I149","article-title":"Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure","volume":"75","author":"Pfeffer","year":"1987","journal-title":"Circulation"},{"key":"2025031314291316600_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10554-019-01528-6","article-title":"Echocardiographic evaluation of left ventricular filling pressures in patients with pulmonary hypertension","volume":"35","author":"Ran","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025031314291316600_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/cpf.12689","article-title":"Prognostic value of left atrial volume index in acute coronary syndrome: a systematic review and meta-analysis","volume":"41","author":"Ahmeti","year":"2021","journal-title":"Clin Physiol Funct Imaging"},{"key":"2025031314291316600_bib33","doi-asserted-by":"crossref","first-page":"Hae0000000000000078","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025031314291316600_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.21873\/invivo.11854","article-title":"Recurrence of atrial fibrillation in dependence of left atrial volume index","volume":"34","author":"Kranert","year":"2020","journal-title":"In Vivo"},{"key":"2025031314291316600_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2025031314291316600_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/eurjhf\/hfp112","article-title":"Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (merge heart failure)","volume":"11","author":"Rossi","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvaf003\/62201328\/pvaf003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/2\/190\/62201328\/pvaf003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/2\/190\/62201328\/pvaf003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T14:29:34Z","timestamp":1741876174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/11\/2\/190\/8045696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf003","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3]]}}}